January 26, 2026 Experience Murphy Oil $500 million notes offering We advised Murphy Oil on its debt offering
January 20, 2026 Experience AbelZeta sale of China rights to GPC3 CAR-T therapy to AstraZeneca We advised AbelZeta on the transaction
January 6, 2026 Experience Mobileye $900 million acquisition of Mentee Robotics We are advising Mobileye on the transaction
January 5, 2026 Experience W. L. Gore & Associates acquisition of Conformal Medical We are advising Gore on the transaction
December 19, 2025 Experience GSK strategic collaboration with CAMP4 Therapeutics We advised GSK on the transaction
December 11, 2025 Experience HNI senior secured notes exchange offer We advised HNI on the exchange offer
December 9, 2025 Experience Emera C$600 million at-the-market offering We advised Emera on the offering
November 19, 2025 Experience Semrush Holdings $1.9 billion sale to Adobe We are advising Semrush on the transaction
November 18, 2025 Experience AkzoNobel $25 billion merger of equals with Axalta Coating Systems We are advising AkzoNobel on the transaction
October 30, 2025 Experience Novo Nordisk proposed $9.1 billion acquisition of Metsera We are advising Novo Nordisk on the transaction